Oct 28 |
Myriad Genetics (MYGN) Earnings Expected to Grow: Should You Buy?
|
Oct 18 |
Myriad Genetics Shares Fall Despite Partnership With jscreen
|
Oct 16 |
Myriad Genetics enters into strategic partnership with jscreen
|
Oct 16 |
Myriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access
|
Oct 15 |
Myriad Genetics and Flatiron Health Partner to Make Genetic Testing More Accessible with Electronic Medical Record Integration
|
Oct 14 |
Myriad Genetics (NASDAQ:MYGN) shareholders are still up 61% over 1 year despite pulling back 7.9% in the past week
|
Oct 11 |
MYGN Taps Ultima Genomics' UG 100 Platform for Advanced Clinical Tests
|
Oct 9 |
Myriad Genetics expects Q3 revenue slightly above Wall Street estimates
|
Oct 9 |
Myriad signs five partnerships to study MRD testing in breast cancer
|
Oct 8 |
Myriad Genetics Announces Five Research Collaborations to Study the Use of MRD Testing in Breast Cancer
|